ADVANCED SOLID MALIGNANCIES
Clinical trials for ADVANCED SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental drug called AZD9574, taken alone or with other anti-cancer medicines, in about 695 people whose advanced solid tumors have grown despite prior treatment. The main goals are to check the drug's safety and find the right dose. Researchers will also …
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat cancers: experimental drug BMS-986523 enters human trials
Disease control Recruiting nowThis study tests a new drug called BMS-986523, alone or with other cancer drugs, in people with advanced solid tumors (like lung, colorectal, or pancreatic cancer) that have a specific genetic change (KRAS mutation). The goal is to see if it is safe and works. About 252 adults wi…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Experimental mitochondrial vaccine takes on advanced cancers
Disease control Recruiting nowThis early-stage trial is testing an engineered mitochondrial vaccine in 12 people with advanced solid tumors who cannot have standard treatments. The vaccine is given as a series of shots to see if it is safe and can help control the cancer. The study focuses on safety first, wi…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for advanced cancer? early trial of BC2027 begins
Disease control Recruiting nowThis early-phase trial is testing a new drug, BC2027, in 180 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors or slow their growth. Participants re…
Matched conditions: ADVANCED SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC